| |
| |
|
| Insider
Information: |
Hughes Thomas E. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
138,074 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$327,973 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,074 |
|
|
| Total
Value |
$327,973 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Larimar Therapeutics Inc |
LRMR |
See Remarks, Director |
2018-06-28 |
125,247 |
|
0 |
Premium* |
|
|
Viridian Therapeutics Ors Shs |
VRDN |
Director |
2018-10-11 |
12,827 |
2017-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2018-10-11 |
4 |
B |
$4.77 |
$47,697 |
D/D |
10,000 |
12,827 |
2.39 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
See Remarks |
• • – |
2018-06-28 |
4 |
AS |
$10.00 |
$320,000 |
D/D |
(32,000) |
125,247 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
See Remarks |
• • – |
2018-03-07 |
4 |
AS |
$10.00 |
$50,000 |
D/D |
(5,000) |
157,247 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2017-12-20 |
4 |
S |
$8.00 |
$96,000 |
D/D |
(12,000) |
2,827 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2017-05-11 |
4 |
OE |
$0.75 |
$74,673 |
D/D |
93,211 |
157,371 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2017-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
778 |
14,840 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2016-08-29 |
4 |
B |
$3.00 |
$29,987 |
D/D |
10,000 |
63,936 |
2.81 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2016-07-22 |
4 |
B |
$3.02 |
$15,104 |
D/D |
5,000 |
53,936 |
2.81 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
President and CEO |
• • – |
2016-07-22 |
4 |
OE |
$0.75 |
$18,750 |
D/D |
25,000 |
48,936 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2016-01-08 |
4 |
OE |
$0.75 |
$7,500 |
D/D |
10,000 |
21,320 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-09-23 |
4 |
OE |
$0.75 |
$7,875 |
D/D |
10,500 |
11,320 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-09-18 |
4 |
AS |
$45.00 |
$1,040,670 |
D/D |
(23,126) |
820 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-09-18 |
4 |
OE |
$2.45 |
$56,659 |
D/D |
23,126 |
23,946 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-09-17 |
4 |
AS |
$40.00 |
$900,000 |
D/D |
(22,500) |
820 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-09-17 |
4 |
OE |
$2.45 |
$11,941 |
D/D |
4,874 |
23,320 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Executive OfficerOfficer |
• • – |
2014-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,253 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
